Breast and Endocrine Surgery

75 soru

Soru 1Soru →

Match each patient's clinical presentation and breast pathology findings with the most appropriate surgical or overall management strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with a 1.5-cm, mobile, non-tender breast mass. Core needle biopsy confirms a fibroadenoma. She prefers to avoid surgery if possible.
A 55-year-old woman diagnosed with a 2-cm unifocal invasive ductal carcinoma. Her axilla is clinically negative, and she strongly desires to preserve her breast.
A 60-year-old woman with a 3-cm invasive carcinoma. Mammography reveals extensive pleomorphic microcalcifications involving three different breast quadrants.
A 45-year-old woman diagnosed with a 3-cm invasive ductal carcinoma. She has fixed, matted axillary lymph nodes that are biopsy-proven for metastasis.
A 38-year-old woman presenting with rapidly progressing diffuse breast erythema and peau d'orange. Biopsy confirms invasive carcinoma with dermal lymphatic invasion.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each specific breast pathology to its definitive guideline-directed management: observation for benign asymptomatic fibroadenomas, lumpectomy for localized disease, mastectomy for multicentric disease, axillary dissection for fixed positive nodes, and neoadjuvant chemotherapy for inflammatory breast cancer.
Each specific clinical scenario dictates a distinct guideline-directed management pathway. Fibroadenomas in asymptomatic patients who do not desire surgery can be safely observed. Early-stage, unifocal breast cancer is ideally treated with breast-conserving therapy (lumpectomy plus radiation) if the patient desires breast preservation and has no contraindications. Multicentric disease (involving multiple quadrants) is an absolute contraindication to breast-conserving therapy, mandating a mastectomy. Patients with clinically positive, fixed or matted axillary lymph nodes require neoadjuvant chemotherapy to downstage the disease, followed by a formal axillary lymph node dissection rather than a sentinel node biopsy. Finally, inflammatory breast cancer (characterized by dermal lymphatic invasion and peau d'orange) is never treated with upfront surgery; it requires immediate neoadjuvant chemotherapy followed by modified radical mastectomy.

Adım Adım Çözüm

1
Evaluate the pathology and extent of disease in each patient scenario.
Identified benign (fibroadenoma), early localized, multicentric, node-positive, and inflammatory presentations.
Definitive surgical indications depend primarily on tumor size, focality, nodal status, and inflammatory features.
2
Determine contraindications for breast-conserving therapy (BCT).
The scenario with extensive microcalcifications across three quadrants has multicentric disease, an absolute contraindication to BCT, thus requiring mastectomy.
BCT requires the ability to achieve clear margins and deliver post-operative radiation without excessive cosmetic failure.
3
Assess indications for upfront systemic therapy.
The patients with fixed axillary nodes and inflammatory breast cancer both require neoadjuvant chemotherapy before any surgical intervention.
Locally advanced and inflammatory breast cancers require systemic downstaging to improve survival and resectability prior to operative management.

Anahtar Kavram

Surgical and Neoadjuvant Management of Breast Disease
Tahmini Süre:2m 0s
Soru 2Soru →

A 3131-year-old man comes to the physician for evaluation of a painless neck mass he noticed while shaving two weeks ago. For the past four months, he has experienced episodic, severe headaches accompanied by profound sweating and palpitations, which he attributed to work-related stress. His blood pressure is 172/98172/98 mm Hg, and his pulse is 108108/min. Physical examination reveals a 2.52.5-cm, firm, mobile, non-tender mass in the right anterior neck. Laboratory studies show a serum thyroid-stimulating hormone (TSH) level of 6.26.2 μ\mu U/mL (normal: 0.40.4–4.04.0 μ\mu U/mL) and a free thyroxine (T4) level of 1.11.1 ng/dL (normal: 0.90.9–2.42.4 ng/dL). An ultrasound of the neck demonstrates a 2.32.3-cm solid, hypoechoic nodule with microcalcifications in the right thyroid lobe. Fine-needle aspiration biopsy of the nodule reveals clusters of spindle-shaped cells with pleomorphic nuclei and extracellular deposits that demonstrate apple-green birefringence under polarized light after Congo red staining. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Evaluation of plasma free metanephrine levels

Cevap

The most appropriate next step is the evaluation of plasma free metanephrine levels to rule out a coexisting pheochromocytoma.
The correct action is to evaluate plasma free metanephrines. This patient's biopsy showing Congo red-positive amyloid deposits and spindle cells confirms medullary thyroid carcinoma (MTC). MTC is frequently associated with Multiple Endocrine Neoplasia type 2 (MEN2), which includes pheochromocytomas. The patient's episodic headaches, sweating, tachycardia, and hypertension are classic signs of a pheochromocytoma. In any patient diagnosed with MTC, a pheochromocytoma MUST be biochemically ruled out (using plasma free metanephrines or 24-hour urine metanephrines and catecholamines) before proceeding with any surgical intervention, including thyroidectomy. Induction of anesthesia or surgical manipulation in an unblocked patient with a pheochromocytoma can precipitate a massive, potentially fatal hypertensive crisis.

Adım Adım Çözüm

1
Interpret the biopsy findings.
Spindle-shaped cells with Congo red-positive extracellular deposits (amyloid) confirm the diagnosis of medullary thyroid carcinoma (MTC).
MTC is characterized by malignant parafollicular C cells that secrete calcitonin, which deposits as amyloid in the surrounding tissue.
2
Correlate the diagnosis with the patient's systemic symptoms.
The combination of MTC and episodic headaches, diaphoresis, tachycardia, and hypertension is highly suspicious for Multiple Endocrine Neoplasia type 2A or 2B (MEN2A/2B).
MEN2 syndromes are characterized by the presence of MTC and pheochromocytoma (a catecholamine-secreting tumor of the adrenal medulla).
3
Determine the optimal preoperative sequence for a patient with suspected MEN2.
Biochemical testing for a pheochromocytoma (via plasma free metanephrines or 24-hour urine metanephrines) must be performed.
If a patient with an undiagnosed and unblocked pheochromocytoma undergoes general anesthesia and surgery (e.g., thyroidectomy), the stress can trigger a massive release of catecholamines, leading to a fatal hypertensive crisis.

Anahtar Kavram

Preoperative evaluation of medullary thyroid carcinoma requires mandatory biochemical screening for a coexisting pheochromocytoma (MEN2) to prevent life-threatening intraoperative hypertensive crisis.

Alternatif Yöntem

Measurement of 24-hour urinary fractionated metanephrines and catecholamines is an equally valid initial screening test for pheochromocytoma.
Tahmini Süre:1m 30s
Soru 3Soru →

A 3232-year-old woman, gravida 22, para 11, at 1818 weeks gestation presents to the clinic after noticing a new mass in her right breast 22 weeks ago. She reports no breast pain, skin changes, or nipple discharge. She has no personal or family history of breast cancer. Vital signs are within normal limits. Physical examination reveals a 33-cm, firm, non-tender, and relatively fixed mass in the upper outer quadrant of the right breast. There is no overlying erythema, warmth, or peau d'orange. Palpation of the right axilla reveals a firm, mobile 1.51.5-cm lymph node. The left breast and axilla are normal. Which of the following is the most appropriate next step in the evaluation of this patient's breast mass?

Cevabı ve açıklamayı göster

Cevap: Targeted ultrasound of the right breast and axilla

Cevap

The most appropriate next step is a targeted ultrasound of the right breast and axilla.
The correct answer is a targeted ultrasound of the right breast and axilla. Breast cancer during pregnancy is rare but can occur, and any dominant, firm, or fixed mass requires prompt evaluation. The physiologic hypertrophy and increased glandular density of the breast during pregnancy and lactation significantly reduce the sensitivity and predictive value of mammography. Therefore, ultrasound is the preferred initial imaging modality. It is highly sensitive, avoids ionizing radiation exposure to the fetus, and can effectively distinguish between simple cysts (e.g., galactoceles) and complex or solid masses. If the ultrasound is suspicious for malignancy, a core needle biopsy is the subsequent definitive step.

Adım Adım Çözüm

1
Identify the primary clinical problem from the vignette.
The patient has a new, 33-cm, firm, fixed breast mass with ipsilateral axillary lymphadenopathy at 1818 weeks gestation.
Establishing the severity and characteristics of the clinical finding dictates the urgency of the workup.
2
Determine the appropriate diagnostic algorithm for a breast mass in pregnancy.
Initial evaluation requires an imaging modality that is safe for the fetus and highly sensitive in the setting of dense breast tissue.
Pregnancy induces physiologic breast hypertrophy, altering the diagnostic utility of standard imaging like mammography.
3
Select the optimal initial imaging modality.
Targeted ultrasound of the breast and axilla is selected as the first step.
Ultrasound provides excellent characterization of solid versus cystic masses in dense breasts without exposing the fetus to ionizing radiation.

Anahtar Kavram

The initial imaging modality of choice for a palpable breast mass during pregnancy or lactation is a targeted ultrasound.
Soru 4Soru →

Match each patient presentation of hyperparathyroidism with the most appropriate surgical management strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 35-year-old patient with primary hyperparathyroidism, nephrolithiasis, and a family history of pituitary adenomas and pancreatic neuroendocrine tumors.
A 60-year-old asymptomatic patient with primary hyperparathyroidism; sestamibi scan and neck ultrasound concordantly localize a single enlarged parathyroid gland in the right lower neck.
A 55-year-old patient with end-stage renal disease on hemodialysis who develops severe bone pain, ectopic calcifications, and a parathyroid hormone level of 1,500 pg/mL despite maximal medical therapy.
A 45-year-old patient with recurrent primary hypercalcemia two years after an initial neck surgery; a current 99mTc-sestamibi scan reveals an area of intense focal uptake in the anterior mediastinum.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations match their respective procedures based on the underlying etiology (multiglandular hyperplasia vs. single adenoma) and the anatomic location of the diseased glands.
Correct surgical management of hyperparathyroidism requires distinguishing between single-gland disease (adenoma) and multiglandular disease (hyperplasia). A single, concordantly localized adenoma is optimally treated with a focused, minimally invasive approach. In contrast, MEN 1 causes multiglandular hyperplasia, necessitating a four-gland exploration and subtotal resection. Severe, refractory secondary hyperparathyroidism from renal failure also involves all four glands and requires total parathyroidectomy with autotransplantation. Finally, a mediastinal ectopic adenoma requires a thoracic approach since it cannot be accessed transcervically.

Adım Adım Çözüm

1
Identify the etiology of the 35-year-old patient's disease.
The family history indicates MEN 1, which causes four-gland hyperplasia.
Knowing the etiology dictates a bilateral exploration (subtotal parathyroidectomy) rather than a focused surgery.
2
Evaluate the imaging results for the 60-year-old patient.
Two different imaging modalities confirm a single localized adenoma.
Concordant localization allows the surgeon to perform a focused, minimally invasive procedure safely.
3
Assess the pathophysiology of the 55-year-old patient on hemodialysis.
End-stage renal disease causes chronic stimulation and subsequent four-gland hyperplasia (secondary/tertiary hyperparathyroidism).
A total parathyroidectomy is needed to remove all hyperfunctioning tissue; forearm autotransplantation preserves some function while keeping the tissue accessible.
4
Determine the anatomic location of the recurrent adenoma in the 45-year-old patient.
The adenoma is located in the anterior mediastinum.
Ectopic glands in the thorax require surgical access via the chest (VATS or sternotomy) rather than the neck.

Anahtar Kavram

The surgical management of hyperparathyroidism is tailored to the disease etiology (single adenoma vs. multiglandular hyperplasia) and the anatomical location of the hyperfunctioning tissue.
Soru 5Soru →

A 35-year-old woman presents to the clinic after noticing a lump in her neck while applying lotion. She denies weight changes, palpitations, heat or cold intolerance, or changes in bowel habits. She has no family history of thyroid disease or head and neck irradiation. Vital signs are within normal limits. Physical examination reveals a 1.5-cm, firm, mobile nodule in the left lobe of the thyroid gland. There is no cervical lymphadenopathy. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 2.8 µU/mL (normal: 0.4–4.0 µU/mL) and a free T4 of 1.2 ng/dL (normal: 0.9–2.4 ng/dL). An ultrasound of the neck demonstrates a 1.6-cm solid, hypoechoic nodule with irregular margins and microcalcifications in the left thyroid lobe. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Fine-needle aspiration biopsy

Cevap

The most appropriate next step is a fine-needle aspiration biopsy of the thyroid nodule.
The correct approach for evaluating a palpable thyroid nodule involves initially checking a serum TSH and performing a neck ultrasound. If the TSH is normal or elevated, the nodule is nonfunctioning, and the risk of malignancy must be assessed via ultrasound. This patient has a 1.6-cm nodule with highly suspicious features (solid, hypoechoic, irregular margins, and microcalcifications). Guidelines recommend fine-needle aspiration (FNA) biopsy for highly suspicious nodules that are >1 cm in diameter to obtain a cytological diagnosis and rule out thyroid cancer.

Adım Adım Çözüm

1
Evaluate the initial laboratory findings for the palpable thyroid nodule.
The patient's TSH level is within normal limits (2.8 µU/mL).
The TSH level determines the functional status of the nodule and dictates whether a functional (radionuclide) scan is required.
2
Assess the ultrasound findings in the context of a normal TSH level.
Ultrasound reveals a 1.6-cm solid, hypoechoic nodule with microcalcifications and irregular margins.
These specific sonographic features are highly suspicious for a thyroid malignancy, such as papillary thyroid carcinoma.
3
Determine the indications for a diagnostic biopsy.
A fine-needle aspiration (FNA) biopsy is indicated.
FNA is required for any solid thyroid nodule >1 cm that exhibits high-risk sonographic features to obtain a definitive cytological diagnosis prior to planning potential surgery.

Anahtar Kavram

Diagnostic algorithm and indications for fine-needle aspiration of a thyroid nodule.
Soru 6Soru →

A 3838-year-old man presents to the clinic complaining of episodic headaches, excessive sweating, and a feeling of a rapid heart rate. His blood pressure in the clinic is 172/105 mmHg172/105 \text{ mmHg}. He reports that these "spells" have been occurring once or twice a week for the past 33 months. Physical examination is otherwise unremarkable. Laboratory evaluation reveals a serum potassium of 4.2 mEq/L4.2 \text{ mEq/L} and fasting blood glucose of 115 mg/dL115 \text{ mg/dL}. A 2424-hour urine collection shows fractionated metanephrines that are 44 times the upper limit of normal. Contrast-enhanced CT of the abdomen reveals a 4.5 cm4.5 \text{ cm} well-circumscribed, lipid-poor mass in the right adrenal gland. The patient is scheduled to undergo a laparoscopic right adrenalectomy in 33 weeks. Which of the following is the most appropriate preoperative pharmacological sequence to prevent perioperative complications?

Cevabı ve açıklamayı göster

Cevap: Initiation of phenoxybenzamine now, with addition of propranolol 33 days prior to surgery

Cevap

Initiation of phenoxybenzamine now, with addition of propranolol 3 days prior to surgery
The correct answer requires the initiation of phenoxybenzamine followed by propranolol. This patient has a classic presentation of a pheochromocytoma, a catecholamine-secreting tumor of the adrenal medulla. The diagnosis is confirmed by elevated 2424-hour urine fractionated metanephrines and an adrenal mass on CT. Surgical resection (adrenalectomy) is the definitive treatment. However, manipulating the tumor during surgery can cause a massive release of catecholamines, leading to a life-threatening hypertensive crisis. Therefore, adequate preoperative pharmacological preparation is essential. The standard of care requires initiating an alpha-adrenergic antagonist (such as phenoxybenzamine or doxazosin) 1010 to 1414 days prior to surgery to control blood pressure and allow for plasma volume expansion. Once adequate alpha-blockade is achieved, a non-cardioselective beta-adrenergic antagonist (such as propranolol) is added 22 to 33 days preoperatively to control tachycardia.

Adım Adım Çözüm

1
Analyze the clinical presentation and diagnostic findings.
The patient has episodic hypertension, tachycardia, headaches, elevated urine metanephrines, and a 4.5 cm4.5 \text{ cm} adrenal mass, confirming the diagnosis of a pheochromocytoma.
Establishing the correct diagnosis is essential to determine the specific perioperative requirements for this unique endocrine tumor.
2
Identify the standard surgical treatment and associated risks.
Laparoscopic adrenalectomy is indicated. The primary risk is a massive release of catecholamines during tumor manipulation, causing a severe hypertensive crisis.
Understanding the surgical risks dictates the necessity of pharmacological blockade prior to the operation.
3
Determine the correct pharmacological sequence to mitigate this risk.
An alpha-blocker (phenoxybenzamine) must be started first for 1010-1414 days to control blood pressure and expand plasma volume. Only after adequate alpha-blockade should a beta-blocker (propranolol) be added to control tachycardia.
Giving a beta-blocker before an alpha-blocker causes unopposed alpha-adrenergic stimulation, which can precipitate a fatal hypertensive crisis.

Anahtar Kavram

In the preoperative management of pheochromocytoma, alpha-adrenergic blockade must always precede beta-adrenergic blockade to prevent unopposed alpha-receptor stimulation and hypertensive crisis.

Alternatif Yöntem

If patients cannot tolerate alpha-blockers due to severe side effects (such as profound orthostatic hypotension), calcium channel blockers (e.g., amlodipine, nifedipine, or nicardipine) can be used for preoperative blood pressure control. Metyrosine, an inhibitor of catecholamine synthesis (tyrosine hydroxylase), can also be added in refractory cases.
Tahmini Süre:1m 15s
Soru 7Soru →

Match the following thyroid nodule presentations and cytology findings with the most appropriate initial surgical or medical management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old woman with a 4.5-cm solid thyroid nodule. Cytology shows papillary thyroid carcinoma. Ultrasound demonstrates no suspicious cervical lymph nodes.
A 40-year-old man with a 1.5-cm thyroid nodule. Cytology shows medullary thyroid carcinoma. Serum basal calcitonin is markedly elevated.
A 32-year-old woman with a 2.5-cm thyroid nodule. TSH is normal. Cytology shows a follicular neoplasm. Molecular testing is not available.
A 50-year-old woman with a 1.2-cm thyroid nodule. Cytology shows a benign colloid nodule. She is asymptomatic and euthyroid.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair papillary thyroid carcinoma > 4 cm with total thyroidectomy, medullary carcinoma with total thyroidectomy plus central neck dissection, follicular neoplasm with diagnostic lobectomy, and benign nodules with observation.
Each nodule requires a specific, distinct management strategy: PTC > 4 cm requires total thyroidectomy; medullary carcinoma requires total thyroidectomy plus central neck dissection due to aggressive lymphatic spread; follicular neoplasms require lobectomy to assess for capsular/vascular invasion; and asymptomatic benign nodules require observation.

Adım Adım Çözüm

1
Evaluate the management for the 4.5-cm papillary thyroid carcinoma.
Matches with 'Total thyroidectomy'.
Tumor size > 4 cm warrants a total thyroidectomy, but lacking clinical nodal involvement, a prophylactic central neck dissection is unnecessary.
2
Evaluate the management for medullary thyroid carcinoma.
Matches with 'Total thyroidectomy with prophylactic central compartment neck dissection'.
Medullary thyroid carcinoma has high rates of early lymphatic spread; standard of care includes prophylactic central neck dissection.
3
Evaluate the management for a follicular neoplasm without available molecular testing.
Matches with 'Diagnostic thyroid lobectomy'.
Cytology cannot distinguish a benign follicular adenoma from a malignant follicular carcinoma; histological evaluation of the capsule and vessels is required via lobectomy.
4
Evaluate the management for an asymptomatic benign colloid nodule.
Matches with 'Observation with routine ultrasound surveillance'.
Benign, asymptomatic nodules do not require surgery and are managed conservatively.

Anahtar Kavram

Surgical management of thyroid nodules depends heavily on the specific cytological diagnosis from fine-needle aspiration, tumor size, and histological subtype.
Tahmini Süre:1m 30s
Soru 8Soru →

During a routine wellness examination, a 5454-year-old woman is found to have an asymmetric thyroid gland. She reports feeling generally well, though she notes a mild increase in anxiety and occasional loose stools over the past two months. Her heart rate is 92/min92/min and blood pressure is 128/78128/78 mmHgmmHg. Physical examination reveals a non-tender, mobile, 2.82.8 cm nodule in the right lobe of the thyroid gland. There is no palpable cervical lymphadenopathy. Laboratory testing reveals:

Thyroid-stimulating hormone (TSH): 0.040.04 μU/mL\mu U/mL (normal: 0.4−4.00.4-4.0 μU/mL\mu U/mL)
Free thyroxine (T4): 2.12.1 ng/dLng/dL (normal: 0.9−1.70.9-1.7 ng/dLng/dL)

A neck ultrasound confirms a 2.82.8 cm solid, hypoechoic right-sided thyroid nodule with increased internal vascularity. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Radionuclide thyroid scintigraphy

Cevap

Radionuclide thyroid scintigraphy
In the evaluation of a newly discovered thyroid nodule, the initial step is to measure serum TSH. If the TSH is subnormal (suppressed), the next required step is radionuclide thyroid scintigraphy (typically using Iodine-123 or Technetium-99m). This test determines whether the nodule is autonomously functioning ('hot') or non-functioning ('cold'). A functioning nodule in the setting of hyperthyroidism (toxic adenoma) has a very low risk of malignancy and typically does not require a fine-needle aspiration (FNA) biopsy, whereas a 'cold' nodule requires further evaluation with FNA to rule out malignancy.

Adım Adım Çözüm

1
Evaluate the patient's laboratory results in conjunction with the physical exam findings.
The patient has a clinically significant 2.82.8 cm thyroid nodule with overt biochemical hyperthyroidism (suppressed TSH and elevated Free T4).
The initial laboratory evaluation of any new thyroid nodule dictates the subsequent diagnostic pathway.
2
Determine the appropriate diagnostic algorithm branch based on the TSH level.
Because the TSH is suppressed, a radionuclide thyroid scan is the required next step.
Scintigraphy is necessary to determine if the nodule is autonomously functioning (hyperfunctioning/'hot') or non-functioning ('cold'). Hyperfunctioning nodules rarely harbor malignancy and typically do not require biopsy.

Anahtar Kavram

The diagnostic algorithm for a thyroid nodule relies heavily on the initial TSH level; a subnormal TSH mandates radionuclide scintigraphy before considering fine-needle aspiration.
Tahmini Süre:1m 15s
Soru 9Soru →

A 4242-year-old woman is evaluated in the hospital on postoperative day 22 following a total thyroidectomy for a large toxic multinodular goiter. Her current medications include levothyroxine. She reports new-onset tingling around her mouth and in the fingertips of both hands. She also mentions mild nausea and states she has not had a bowel movement since before the surgery. She has no difficulty breathing or voice changes. Vital signs are temperature 38.0∘C38.0^{\circ}\text{C} (100.4∘F100.4^{\circ}\text{F}), blood pressure 122/78 mmHg122/78\text{ mmHg}, heart rate 84/min84/\text{min}, and respiratory rate 14/min14/\text{min}. Physical examination reveals twitching of the ipsilateral facial muscles when the area just anterior to the earlobe is tapped. The surgical incision is clean, dry, and intact without erythema or fluctuance. The lungs are clear to auscultation. The abdomen is soft and non-distended with hypoactive bowel sounds.

Laboratory results are as follows:

Laboratory TestResultReference Range
Serum total calcium7.5 mg/dL7.5\text{ mg/dL}8.4−10.2 mg/dL8.4 - 10.2\text{ mg/dL}
Serum albumin4.0 g/dL4.0\text{ g/dL}3.5−5.0 g/dL3.5 - 5.0\text{ g/dL}
Serum phosphorus5.2 mg/dL5.2\text{ mg/dL}2.5−4.5 mg/dL2.5 - 4.5\text{ mg/dL}
Serum intact parathyroid hormone8 pg/mL8\text{ pg/mL}15−65 pg/mL15 - 65\text{ pg/mL}
Serum TSH0.1 \muU/mL0.1\text{ \mu U/mL}0.4−4.0 \muU/mL0.4 - 4.0\text{ \mu U/mL}
Serum free T41.9 ng/dL1.9\text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7\text{ ng/dL}

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Oral administration of calcium carbonate and calcitriol

Cevap

The most appropriate next step is the oral administration of calcium carbonate and calcitriol.
The correct answer is oral administration of calcium carbonate and calcitriol. This patient presents with perioral tingling and a positive Chvostek sign on postoperative day 2 following a total thyroidectomy. Her laboratory results confirm hypocalcemia, hyperphosphatemia, and an inappropriately low parathyroid hormone (PTH) level, establishing the diagnosis of primary hypoparathyroidism. This is a well-known complication of total thyroidectomy caused by inadvertent injury, devascularization, or removal of the parathyroid glands. Because her symptoms are mild (paresthesias and Chvostek sign without severe features like tetany, carpopedal spasm, seizures, or arrhythmias), the most appropriate management is oral calcium supplementation combined with calcitriol (1,25-dihydroxycholecalciferol). Calcitriol is necessary because the lack of PTH impairs the renal conversion of 25-hydroxyvitamin D to its active form. Intravenous calcium gluconate is reserved for severe, life-threatening symptoms or a serum calcium level strictly below 7.0 mg/dL7.0\text{ mg/dL}.

Adım Adım Çözüm

1
Evaluate the patient's acute symptoms and physical examination findings.
Identified perioral tingling and a positive Chvostek sign (facial muscle twitching).
These are classic signs of neuromuscular irritability indicating clinical hypocalcemia.
2
Analyze the laboratory results in the context of recent surgery.
Confirmed hypocalcemia (7.5 mg/dL7.5\text{ mg/dL}) and hyperphosphatemia with inappropriately low parathyroid hormone (8 pg/mL8\text{ pg/mL}).
To diagnose postoperative primary hypoparathyroidism, a known complication of total thyroidectomy.
3
Determine the appropriate severity-based treatment for hypocalcemia.
Selected oral calcium carbonate and calcitriol.
The patient has mild to moderate symptoms without life-threatening features (e.g., tetany, arrhythmias), which warrants oral replacement rather than intravenous calcium.
4
Assess other clinical findings to ensure no other emergent interventions are required.
Identified low-grade fever and mild ileus as normal postoperative day 2 findings, and recognized suppressed TSH as an expected residual effect of toxic multinodular goiter.
To rule out infection, deep vein thrombosis, or bowel obstruction, and confirm that conservative management of these secondary findings is appropriate.

Anahtar Kavram

Mild to moderate symptomatic postoperative hypocalcemia following thyroidectomy is managed with oral calcium and calcitriol, prioritizing acute stabilization over expected postoperative lab abnormalities or normal physiologic surgical responses.
Soru 10Soru →

A 5151-year-old male is evaluated in the surgical oncology clinic for a newly discovered neck mass. Two weeks ago, he underwent a carotid duplex ultrasound as part of a workup for transient visual changes, which incidentally revealed a 2.6 cm2.6\text{ cm} solid nodule in the right thyroid lobe. The patient reports an 88-month history of progressive fatigue, decreased libido, and feeling cold constantly. He has no personal or family history of head and neck irradiation or thyroid malignancy. His blood pressure is 108/68 mmHg108/68\text{ mmHg} and pulse is 54/min54\text{/min}. Physical examination shows a firm, non-tender nodule palpable in the right anterior neck. No cervical lymphadenopathy is present. Testicular examination reveals bilaterally small, soft testes. Laboratory studies show:

Thyroid-stimulating hormone (TSH): 0.12 \muU/mL0.12\text{ \mu U/mL} (normal: 0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL})
Free thyroxine (T4): 0.5 ng/dL0.5\text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's thyroid nodule?

Cevabı ve açıklamayı göster

Cevap: Comprehensive ultrasound of the thyroid gland

Cevap

Comprehensive ultrasound of the thyroid gland
The correct next step is a comprehensive ultrasound of the thyroid gland. The first step in evaluating a thyroid nodule is measuring serum TSH. A low TSH typically prompts radionuclide scintigraphy to identify a benign, hyperfunctioning ('hot') nodule. However, this algorithm assumes primary thyroid pathology. This patient has low TSH, low free T4, and symptoms of hypogonadism, which indicates central hypothyroidism due to pituitary dysfunction. Because the low TSH is caused by pituitary failure rather than suppression by an autonomously functioning nodule, the nodule is non-functioning. Therefore, it carries the standard risk of malignancy and must be evaluated with a dedicated thyroid ultrasound to assess its sonographic features (e.g., margins, microcalcifications) before proceeding to fine-needle aspiration.

Adım Adım Çözüm

1
Analyze the laboratory results in the context of the clinical presentation.
The patient has a low TSH and a low free T4, which, combined with symptoms of hypogonadism (decreased libido, small testes), indicates panhypopituitarism resulting in central (secondary) hypothyroidism.
Accurate interpretation of the thyroid axis is required to determine the functional status of the nodule.
2
Determine the functional status of the incidentally discovered thyroid nodule.
Because the low TSH is driven by pituitary failure and not by excess thyroid hormone production, the nodule is not autonomously hyperfunctioning (not a 'hot' nodule).
If the nodule were hyperfunctioning, the free T4 would be elevated or high-normal.
3
Apply the standard evaluation algorithm for a non-functioning thyroid nodule.
Non-functioning thyroid nodules (those with normal or high TSH, or low TSH due to central causes) require a dedicated neck ultrasound to evaluate sonographic features and size.
Ultrasound risk stratification determines whether a fine-needle aspiration (FNA) biopsy is indicated to rule out malignancy.

Anahtar Kavram

Evaluation of a thyroid nodule in a patient with central hypothyroidism
Soru 11Soru →

Match each clinical presentation of an adrenal mass with the most appropriate specific perioperative or surgical management step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old patient with episodic palpitations, diaphoresis, elevated plasma fractionated metanephrines, and a 4.5-cm adrenal mass.
A 38-year-old patient with resistant hypertension, muscle cramps, low serum potassium, high aldosterone-to-renin ratio, and a 2-cm unilateral adrenal mass.
A 50-year-old patient with central adiposity, proximal muscle weakness, elevated 24-hour urine free cortisol, suppressed ACTH, and a 3.5-cm adrenal mass.
A 55-year-old patient with abdominal pain, a rapidly enlarging 9-cm heterogeneous adrenal mass with irregular margins on CT, and elevated serum DHEA-S.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Pheochromocytoma pairs with alpha/beta blockade; Conn syndrome pairs with aldosterone antagonists; Adrenal Cushing syndrome pairs with postoperative glucocorticoids; Adrenocortical carcinoma pairs with open en bloc resection.
Each adrenal pathology requires distinct surgical planning. Pheochromocytoma requires sequential alpha then beta blockade to prevent intraoperative hypertensive crisis. Primary hyperaldosteronism requires potassium repletion and mineralocorticoid receptor blockade. Adrenal Cushing syndrome causes contralateral gland atrophy, necessitating perioperative stress-dose glucocorticoids to prevent acute adrenal insufficiency after tumor removal. Large, suspicious masses (adrenocortical carcinoma) require open en bloc resection to avoid capsular rupture and tumor seeding, which are risks with laparoscopic approaches and percutaneous biopsies.

Adım Adım Çözüm

1
Analyze the clinical, laboratory, and imaging findings for each adrenal mass presentation to establish the underlying diagnosis.
Identified diagnoses are pheochromocytoma, primary hyperaldosteronism, adrenal Cushing syndrome, and adrenocortical carcinoma.
Each type of functional or malignant adrenal tumor has distinct physiologic consequences that dictate perioperative management.
2
Determine the specific pathophysiologic risks associated with the surgical removal of each tumor type.
Pheochromocytoma risks hypertensive crisis; Conn syndrome involves potassium wasting and hypertension; Cushing syndrome risks postoperative adrenal crisis due to HPA axis suppression; Adrenocortical carcinoma risks tumor spillage and local invasion.
Surgical and perioperative strategies are tailored to mitigate these life-threatening complications.
3
Match the diagnosis with the standard-of-care surgical and perioperative intervention.
Correct pairings are made based on surgical guidelines for endocrine pathology.
Ensures adherence to best practices in endocrine surgery and patient safety.

Anahtar Kavram

Perioperative and surgical management of functioning and malignant adrenal tumors
Soru 12Soru →

A 42-year-old woman comes to the clinic for evaluation of a newly noticed lump in her anterior neck. She reports no pain, hoarseness, dysphagia, or recent changes in her weight. Physical examination reveals a non-tender, 2.5-cm, mobile nodule in the right lobe of the thyroid gland. A neck ultrasound confirms a 2.5-cm solid, hypoechoic nodule in the right thyroid lobe with regular margins. Laboratory studies show a serum thyroid-stimulating hormone (TSH) level of 0.1 mU/L (normal: 0.4-4.0 mU/L). Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Radionuclide thyroid scan

Cevap

Radionuclide thyroid scan
According to the standard diagnostic algorithm for thyroid nodules, the initial evaluation requires a serum TSH level and a thyroid ultrasound. If the TSH is subnormal (suppressed), a radionuclide thyroid scan (e.g., using Iodine-123 or Technetium-99m) is indicated to assess the functional status of the nodule. Hyperfunctioning ('hot') nodules are rarely malignant and typically require evaluation and treatment for hyperthyroidism rather than biopsy. Non-functioning ('cold') nodules have a higher risk of malignancy and generally require a subsequent fine-needle aspiration biopsy.

Adım Adım Çözüm

1
Identify the primary clinical problem and initial findings.
The patient has a palpable 2.5-cm solid thyroid nodule confirmed by ultrasound.
Establishing the baseline clinical scenario is required before interpreting the diagnostic algorithm.
2
Evaluate the initial laboratory results.
The serum TSH level is 0.1 mU/L, which is suppressed (below the normal range).
The TSH value dictates the diagnostic pathway for evaluating a thyroid nodule.
3
Determine the next indicated step based on the TSH level.
A radionuclide thyroid scan is chosen.
When TSH is subnormal, a radionuclide scan is required to determine if the nodule is hyperfunctioning (hot) or non-functioning (cold), as hot nodules are rarely malignant.

Anahtar Kavram

Evaluation of a thyroid nodule with a suppressed TSH level
Soru 13Soru →

A 4646-year-old woman is referred to the endocrine surgery clinic for evaluation of a neck mass discovered 33 weeks ago. She reports a 66-month history of severe fatigue, generalized weakness, and a 55 kg (1111 lb) unintended weight gain. She has not seen a physician in several years. Her medical history is notable for a complicated vaginal delivery 1515 years ago that required multiple blood transfusions and an extended intensive care unit stay. She currently takes no medications. Vital signs are blood pressure 92/5892/58 mmHg and heart rate 6262/min. Physical examination reveals a 3.53.5 cm, firm, mobile nodule in the right thyroid lobe. She is noted to have pale skin and sparse axillary and pubic hair.

Laboratory studies show:
Thyroid-stimulating hormone (TSH): 0.20.2 μ\mu U/mL (Normal: 0.50.5 - 5.05.0 μ\mu U/mL)
Free thyroxine (T4): 0.50.5 ng/dL (Normal: 0.90.9 - 1.71.7 ng/dL)

An ultrasound-guided fine-needle aspiration of the nodule reveals findings suspicious for papillary thyroid carcinoma (Bethesda Category V). The surgical team is planning to schedule a total thyroidectomy. Which of the following is the most appropriate next step in management prior to surgical intervention?

Cevabı ve açıklamayı göster

Cevap: Measurement of early morning serum cortisol

Cevap

Measurement of early morning serum cortisol to evaluate for concomitant central adrenal insufficiency.
The patient's laboratory results demonstrate a low free T4 with an inappropriately low TSH, which is diagnostic of central (secondary) hypothyroidism. Combined with her history of a complicated delivery with severe hemorrhage, hypotension, and sparse body hair, this clinical picture strongly suggests Sheehan syndrome (postpartum pituitary necrosis). In panhypopituitarism, central adrenal insufficiency (decreased ACTH and cortisol) typically coexists with central hypothyroidism. A major physiological stressor like a total thyroidectomy for her newly diagnosed papillary thyroid carcinoma can precipitate a life-threatening acute adrenal crisis (severe shock and cardiovascular collapse) if cortisol is not replaced. Additionally, initiating thyroid hormone replacement (levothyroxine) accelerates hepatic cortisol metabolism and can independently trigger an adrenal crisis. Therefore, the essential next step before initiating any medical or surgical treatment is to evaluate the adrenal axis with an early morning serum cortisol level.

Adım Adım Çözüm

1
Interpret the thyroid function tests.
The patient has both a low TSH and a low free T4.
This discordant pattern indicates central (secondary) hypothyroidism due to a pituitary or hypothalamic failure, rather than primary thyroid pathology.
2
Synthesize laboratory findings with the clinical history and physical exam.
History of postpartum hemorrhage requiring transfusions, coupled with fatigue, hypotension, and loss of axillary/pubic hair, strongly suggests Sheehan syndrome (postpartum pituitary necrosis).
Ischemic necrosis of the pituitary gland results in panhypopituitarism, affecting multiple hormone axes (TSH, ACTH, FSH/LH, etc.).
3
Identify the immediate life-threatening risk associated with surgery in this patient.
The patient is at extremely high risk for an acute adrenal crisis.
Panhypopituitarism implies a lack of ACTH, causing secondary adrenal insufficiency. The physiological stress of total thyroidectomy requires a robust cortisol response that this patient cannot mount.
4
Determine the necessary preoperative intervention.
Measure early morning serum cortisol (and potentially ACTH) to confirm adrenal insufficiency before giving any treatments or proceeding to surgery.
Glucocorticoids must be replaced before surgery to survive the stress response, and absolutely before initiating levothyroxine, which increases cortisol metabolism.

Anahtar Kavram

Preoperative evaluation of central hypothyroidism and the necessity of ruling out concomitant adrenal insufficiency before initiating levothyroxine or proceeding to surgery.
Soru 14Soru →

A 45-year-old woman is referred to the surgical clinic for evaluation of a neck mass she noticed while applying lotion. She reports a 4-kg (8.8-lb) weight loss over the past 3 months despite an increased appetite, as well as occasional palpitations. She has no personal or family history of head and neck irradiation or endocrine malignancies. Vital signs are within normal limits except for a heart rate of 102/min. Physical examination reveals a 3-cm, firm, non-tender, mobile nodule in the right thyroid lobe. Laboratory studies show:

Thyroid-stimulating hormone (TSH): 0.05 µU/mL (normal: 0.4–4.0 µU/mL)
Free thyroxine (T4): 2.4 ng/dL (normal: 0.8–1.8 ng/dL)

A dedicated neck ultrasound demonstrates a 3.2-cm solid, markedly hypoechoic nodule in the right lobe with irregular margins and internal microcalcifications. No abnormal cervical lymph nodes are identified. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Radionuclide thyroid imaging

Cevap

Radionuclide thyroid imaging
The correct answer is radionuclide thyroid imaging. The initial evaluation of any thyroid nodule greater than 1 cm begins with a serum TSH level and a targeted thyroid ultrasound. When the TSH is subnormal (indicating overt or subclinical hyperthyroidism), the most appropriate next step is a radionuclide thyroid scan (using iodine-123 or technetium-99m) to determine the functional status of the nodule. If the scan demonstrates a hyperfunctioning ('hot') nodule, the risk of malignancy is extremely low, and a fine-needle aspiration (FNA) biopsy is contraindicated, regardless of how suspicious the ultrasound features appear. If the nodule is nonfunctioning ('cold'), an FNA biopsy is then indicated based on the ultrasound criteria. This question tests the physician's ability to rigidly adhere to the diagnostic algorithm despite alarming sonographic features.

Adım Adım Çözüm

1
Analyze the patient's clinical and laboratory presentation.
The patient has a 3-cm palpable thyroid nodule with symptomatic thyrotoxicosis, confirmed by a suppressed TSH and elevated Free T4.
Establishing the biochemical thyroid status is the mandatory first step in evaluating any thyroid nodule >1 cm.
2
Evaluate the ultrasound findings.
The ultrasound shows high-risk features for malignancy (solid, hypoechoic, irregular margins, microcalcifications).
Ultrasound determines the size and suspicious characteristics of the nodule.
3
Apply the standard diagnostic algorithm for a thyroid nodule based on the TSH level.
Because the TSH is subnormal, the algorithm requires a radionuclide thyroid scan as the immediate next step, overriding the ultrasound features.
A radionuclide scan differentiates a hyperfunctioning ('hot') nodule from a nonfunctioning ('cold') nodule. Hyperfunctioning nodules have an extremely low risk of malignancy (<1%) and do not require fine-needle aspiration, whereas cold nodules with suspicious features must be biopsied.

Anahtar Kavram

Diagnostic workup of a thyroid nodule with a suppressed TSH requires radionuclide imaging prior to any consideration of fine-needle aspiration.
Tahmini Süre:1m 30s
Soru 15Soru →

Match each clinical presentation of an endocrine lesion with its most appropriate diagnostic or surgical management step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old woman with a 2-cm thyroid nodule, decreased TSH, elevated free T4, and increased uptake on a radionuclide scan.
A 55-year-old man with a 1.5-cm thyroid nodule, normal TSH, and fine-needle aspiration demonstrating intranuclear inclusions and grooved nuclei.
A 60-year-old woman with asymptomatic hypercalcemia of 11.2 mg/dL, elevated intact parathyroid hormone, and a 24-hour urine calcium of 350 mg.
A 40-year-old man with an incidentally discovered 5-cm adrenal mass and significantly elevated 24-hour urine fractionated metanephrines.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align each specific endocrine pathology (toxic adenoma, papillary thyroid carcinoma, primary hyperparathyroidism, and pheochromocytoma) with its standard diagnostic and perioperative surgical management.
Each matching pair appropriately links the clinical endocrine pathology with the standard of care. Toxic adenomas do not require FNA and are managed definitively. Papillary thyroid carcinomas require surgical excision. Primary hyperparathyroidism is treated with parathyroidectomy after localization. Pheochromocytomas require mandatory alpha-blockade to prevent life-threatening intraoperative hemodynamic instability.

Adım Adım Çözüm

1
Evaluate the patient with a low TSH, high T4, and a 'hot' nodule on radionuclide scan.
Identify the lesion as a toxic adenoma.
Hyperfunctioning nodules have a very low risk of malignancy, so fine-needle aspiration is bypassed in favor of definitive therapy (surgery or radioactive iodine).
2
Analyze the cytology findings of intranuclear inclusions and grooved nuclei in a euthyroid patient with a nodule.
Diagnose papillary thyroid carcinoma.
These are classic histologic features requiring surgical resection via lobectomy or total thyroidectomy.
3
Interpret the laboratory panel showing hypercalcemia, elevated PTH, and high 24-hour urine calcium.
Confirm the diagnosis of primary hyperparathyroidism.
Elevated urine calcium distinguishes this from familial hypocalciuric hypercalcemia, indicating that surgical removal of the hyperfunctioning gland is appropriate.
4
Assess the adrenal mass presenting with elevated fractionated metanephrines.
Identify the tumor as a pheochromocytoma.
Medical preparation with alpha-blockade (e.g., phenoxybenzamine) is mandatory prior to surgical resection to control blood pressure during tumor manipulation.

Anahtar Kavram

Diagnostic workup and perioperative surgical management of thyroid, parathyroid, and adrenal lesions.
Soru 16Soru →

A 62-year-old woman is evaluated in the endocrine surgery clinic for a 3.5 cm3.5\text{ cm} right-sided thyroid nodule that she noticed while swallowing. She reports mild localized discomfort but no voice changes. She also notes a 6-month history of profound fatigue, intermittent dizziness upon standing, and decreased appetite. Her medical history is unremarkable, and she takes no medications.

Physical examination reveals a firm, mobile, non-tender nodule in the right thyroid lobe. Her blood pressure is 92/58 mmHg92/58\text{ mmHg} while supine and 80/50 mmHg80/50\text{ mmHg} upon standing. Her heart rate is 82/min82/\text{min}.

Neck ultrasound demonstrates a solid, hypoechoic 3.5 cm3.5\text{ cm} nodule with microcalcifications in the right lobe. Fine-needle aspiration biopsy reveals a follicular neoplasm (Bethesda category IV), and a diagnostic right thyroid lobectomy is planned.

Preoperative laboratory studies show:
Laboratory TestResultReference Range
Hemoglobin11.2 g/dL11.2\text{ g/dL}12.0−16.0 g/dL12.0-16.0\text{ g/dL}
Sodium133 mEq/L133\text{ mEq/L}136−145 mEq/L136-145\text{ mEq/L}
Potassium4.1 mEq/L4.1\text{ mEq/L}3.5−5.0 mEq/L3.5-5.0\text{ mEq/L}
Thyroid-stimulating hormone (TSH)0.1 \muU/mL0.1\text{ \mu U/mL}0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL}
Free thyroxine (T4)0.5 ng/dL0.5\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Assessment of morning serum cortisol and adrenocorticotropic hormone (ACTH) levels

Cevap

Assessment of morning serum cortisol and adrenocorticotropic hormone (ACTH) levels
This patient's laboratory results (low free T4 and inappropriately low TSH) are diagnostic of central (secondary) hypothyroidism. The presence of central hypothyroidism raises a strong suspicion for panhypopituitarism (e.g., due to a nonfunctioning pituitary macroadenoma). Her clinical signs of orthostatic hypotension, profound fatigue, and mild hyponatremia are highly consistent with concurrent central adrenal insufficiency (decreased ACTH and cortisol). Surgery represents a major physiologic stress that requires an intact adrenal response. If a patient with untreated adrenal insufficiency undergoes surgery, they are at extreme risk of developing a life-threatening acute adrenal crisis (refractory hypotension, shock). Therefore, the most critical next step is to evaluate the pituitary-adrenal axis by measuring morning serum cortisol and ACTH levels. If adrenal insufficiency is confirmed, glucocorticoid replacement must be initiated before surgery and before starting levothyroxine. (Levothyroxine increases the metabolic clearance of cortisol and can precipitate an adrenal crisis if given alone).

Adım Adım Çözüm

1
Analyze the preoperative laboratory results.
The patient has both an inappropriately low TSH and a low free T4.
To determine the patient's baseline thyroid function before surgery.
2
Identify the etiology of the thyroid function abnormalities.
The combination of low TSH and low free T4 indicates central (secondary) hypothyroidism.
A low free T4 with a low or normal TSH localizes the endocrine defect to the pituitary gland or hypothalamus.
3
Correlate the pituitary dysfunction with the clinical presentation.
The patient's orthostatic hypotension, fatigue, and hyponatremia suggest concurrent central adrenal insufficiency.
Pituitary adenomas or other central lesions often cause multiple anterior pituitary hormone deficiencies (panhypopituitarism).
4
Determine the perioperative risk and select the next best step.
The pituitary-adrenal axis must be evaluated with morning cortisol and ACTH before surgery or levothyroxine administration.
Operating on a patient with undiagnosed adrenal insufficiency can precipitate a fatal adrenal crisis. Similarly, levothyroxine increases cortisol clearance, which can also trigger a crisis.

Anahtar Kavram

Patients diagnosed with central hypothyroidism must be evaluated for concurrent central adrenal insufficiency before undergoing surgery or initiating levothyroxine therapy to prevent an acute adrenal crisis.
Tahmini Süre:1m 30s
Soru 17Soru →

Match the following common breast pathologies with their classic clinical presentations.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Fibroadenoma
Fibrocystic changes
Intraductal papilloma
Inflammatory breast cancer

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Fibroadenoma pairs with the painless, mobile mass in a young woman. Fibrocystic changes pair with cyclic, bilateral tender masses. Intraductal papilloma pairs with unilateral bloody nipple discharge. Inflammatory breast cancer pairs with rapid erythema and peau d'orange.
Proper diagnosis of breast complaints relies on the direct pattern recognition of key clinical features. Age, pain, mobility, relationship to the menstrual cycle, and overlying skin changes are critical distinguishing factors between common benign entities (like fibroadenomas and fibrocystic changes) and specific malignancies (like inflammatory breast cancer).

Adım Adım Çözüm

1
Identify the characteristic presentation of a fibroadenoma.
It matches the painless, firm, mobile mass in a woman under 30.
Fibroadenomas are the most common benign breast tumors in this age group, known for their distinct mobility on physical exam.
2
Identify the characteristic presentation of fibrocystic changes.
It matches the bilateral, tender masses that fluctuate with the menstrual cycle.
These benign breast changes are hormonally driven, causing cyclical pain and nodularity in the breast tissue.
3
Identify the characteristic presentation of an intraductal papilloma.
It matches the unilateral bloody nipple discharge without a palpable mass.
A benign papilloma located within a lactiferous duct is prone to bleeding, causing the distinct unilateral discharge.
4
Identify the characteristic presentation of inflammatory breast cancer.
It matches the rapidly progressive erythema, swelling, and peau d'orange.
Dermal lymphatic invasion by tumor cells causes marked edema of the skin, resulting in the classic 'orange peel' appearance and rapid onset of symptoms.

Anahtar Kavram

Clinical presentation of benign and malignant breast pathologies
Soru 18Soru →

Match the following clinical presentations of patients with adrenal masses or adrenal dysfunction to the most appropriate next step in management or surgical intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old patient with a 6.5-cm right adrenal mass. Unenhanced CT Hounsfield units (HU) = 35. Biochemical evaluation for hypercortisolism, primary aldosteronism, and pheochromocytoma is normal.
A 45-year-old patient with resistant hypertension and hypokalemia. CT abdomen is normal. Adrenal vein sampling (AVS) Aldosterone/Cortisol ratios: Right = 15, Left = 12, Inferior Vena Cava (IVC) = 10.
A 45-year-old patient with resistant hypertension and hypokalemia. CT shows a 1.5-cm left adrenal nodule. AVS Aldosterone/Cortisol ratios: Left = 25, Right = 2, IVC = 5.
A 60-year-old patient with an incidentally discovered 3.5-cm left adrenal mass. Unenhanced CT HU = 5. Morning cortisol after 1-mg dexamethasone suppression is 1.1 µg/dL. Plasma metanephrines are normal.
A 40-year-old patient with episodic severe headaches and tachycardia. CT abdomen shows a 4.5-cm right adrenal mass with unenhanced HU = 35. Plasma free metanephrines are markedly elevated.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations map specifically to their optimal management paths: suspicious masses require open surgery, non-functioning adenomas require observation, bilateral aldosteronism is managed medically, unilateral aldosteronomas are removed laparoscopically, and pheochromocytomas require sequential medical blockade prior to laparoscopic removal.
Optimal management of adrenal lesions depends on differentiating benign adenomas from adrenocortical carcinoma (using size cutoffs and unenhanced HU < 10) and identifying hormone hypersecretion. Primary aldosteronism requires AVS to definitively differentiate unilateral from bilateral disease. Pheochromocytoma requires proper preoperative sequential medical blockade.

Adım Adım Çözüm

1
Evaluate the 6.5-cm, HU=35 non-functioning mass.
Identify high risk for adrenocortical carcinoma.
Size > 4 cm and unenhanced HU > 10 indicate a suspicious lesion requiring open surgical resection.
2
Calculate the AVS lateralization index for the patient with normal CT.
Ratio = 1.25, indicating bilateral hyperplasia.
A lateralization index < 3 confirms bilateral disease, which is treated medically.
3
Calculate the AVS lateralization index for the patient with the 1.5-cm left nodule.
Ratio = 12.5, indicating a unilateral left aldosteronoma.
A lateralization index > 4 confirms unilateral disease, making the patient a candidate for laparoscopic adrenalectomy.
4
Evaluate the 3.5-cm, HU=5 non-functioning mass.
Identify a benign, non-functioning lipid-rich adenoma.
Size < 4 cm, HU < 10, and negative biochemical workup require only serial observation.
5
Determine the preoperative management for the patient with elevated metanephrines.
Identify pheochromocytoma requiring sequential blockade.
Alpha-blockade must be initiated before beta-blockade to prevent unopposed alpha-adrenergic stimulation.

Anahtar Kavram

Surgical management of adrenal masses requires integration of tumor size, unenhanced Hounsfield units, biochemical functionality, and adrenal vein sampling lateralization.
Tahmini Süre:3m 0s
Soru 19Soru →

A 3838-year-old man presents to the office to evaluate a newly discovered mass in his neck. He first noticed it while shaving two weeks ago. The patient reports no dysphagia, hoarseness, palpitations, headaches, or diaphoresis. He was adopted as a child and his family medical history is unknown. He takes no medications. Vital signs include a blood pressure of 152/94152/94 mm Hg and a heart rate of 8888/min. Physical examination reveals a 2.72.7-cm, firm, non-tender nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is appreciated. Laboratory testing shows a serum thyroid-stimulating hormone level of 1.81.8 μU/mL\mu\text{U}/\text{mL} (normal: 0.40.4-4.04.0 μU/mL\mu\text{U}/\text{mL}). An ultrasound of the neck confirms a solid, hypoechoic right thyroid nodule with irregular margins. A subsequent fine-needle aspiration biopsy of the nodule yields cytology consistent with medullary thyroid carcinoma. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Assessment of plasma fractionated metanephrines

Cevap

The correct answer is the assessment of plasma fractionated metanephrines.
The most appropriate next step in management is the assessment of plasma fractionated metanephrines. This patient has a biopsy-confirmed medullary thyroid carcinoma (MTC). MTC is a neuroendocrine tumor arising from the parafollicular C cells of the thyroid gland. Up to 25%25\% of MTC cases occur as part of a familial syndrome, specifically Multiple Endocrine Neoplasia (MEN) type 2A or 2B. Both of these syndromes are characterized by a high risk of developing a pheochromocytoma (a catecholamine-secreting tumor of the adrenal medulla). Because this patient is adopted, his family history is unknown, making a hereditary syndrome entirely possible. If a patient with an undiagnosed pheochromocytoma undergoes induction of anesthesia and surgical manipulation, the resulting physiologic stress can precipitate a massive release of catecholamines. This leads to a life-threatening intraoperative hypertensive crisis, arrhythmias, and potentially death. Therefore, it is absolutely mandatory to screen all patients with MTC for a coexisting pheochromocytoma using biochemical tests (such as plasma fractionated free metanephrines or 24-hour urine metanephrines and catecholamines) before proceeding with a thyroidectomy. If a pheochromocytoma is diagnosed, it must be surgically resected first, following appropriate preoperative alpha- and beta-adrenergic blockade.

Adım Adım Çözüm

1
Analyze the fine-needle aspiration (FNA) biopsy result.
The patient is diagnosed with medullary thyroid carcinoma (MTC).
Establishing the specific histologic subtype of the thyroid nodule dictates the entire subsequent evaluation and treatment pathway.
2
Recall the systemic associations and genetic implications of MTC.
MTC is strongly associated with Multiple Endocrine Neoplasia (MEN) types 2A and 2B, both of which feature pheochromocytomas.
Even in seemingly sporadic cases (especially in a patient with an unknown family history), a RET proto-oncogene mutation and an occult pheochromocytoma may be present.
3
Determine the safety prerequisites for surgical intervention.
A pheochromocytoma must be definitively ruled out before inducing anesthesia for a thyroidectomy.
Surgical stress and anesthetic agents can trigger a massive catecholamine release from an undiagnosed pheochromocytoma, leading to a catastrophic intraoperative hypertensive crisis.
4
Select the appropriate diagnostic test to screen for the critical comorbidity.
Measure plasma fractionated metanephrines (or 24-hour urine metanephrines and catecholamines).
This is the most sensitive initial biochemical test to evaluate for a catecholamine-secreting adrenal tumor.

Anahtar Kavram

Before undergoing thyroidectomy, all patients newly diagnosed with medullary thyroid carcinoma must be biochemically screened for a coexisting pheochromocytoma (e.g., using plasma fractionated metanephrines) to prevent a life-threatening intraoperative hypertensive crisis.
Soru 20Soru →

A 31-year-old female patient schedules an appointment to discuss persistent bilateral breast secretions that began four months ago. She also reports feeling unusually sluggish, experiencing new-onset constipation, and gaining 5 kg5\text{ kg} (11 lbs11\text{ lbs}) during this timeframe. Her menstrual periods, previously predictable, are now occurring every 45 to 50 days. A home pregnancy test taken last week was negative. She is not taking any over-the-counter or prescription medications. Vital signs show a heart rate of 58/min58\text{/min} and a blood pressure of 110/70 mmHg110/70\text{ mmHg}. On physical examination, there are no palpable masses, skin dimpling, or axillary lymphadenopathy. Gentle expression yields a milky white fluid from both nipples.

Laboratory testing reveals the following:

TestResultReference Range
Prolactin88 ng/mL88\text{ ng/mL}4−23 ng/mL4-23\text{ ng/mL}
Thyroid-stimulating hormone (TSH)24.2 \muU/mL24.2\text{ \mu U/mL}0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL}
Free T40.5 ng/dL0.5\text{ ng/dL}0.8−1.8 ng/dL0.8-1.8\text{ ng/dL}

Based on these findings, which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Start daily oral levothyroxine supplementation

Cevap

The most appropriate next step is to start daily oral levothyroxine supplementation to treat the underlying primary hypothyroidism.
The correct next step is to start daily oral levothyroxine supplementation. This patient presents with classic symptoms of primary hypothyroidism (fatigue, weight gain, constipation, bradycardia) confirmed by an elevated TSH and low Free T4. In primary hypothyroidism, the lack of circulating thyroid hormones removes negative feedback on the hypothalamus, resulting in increased secretion of thyrotropin-releasing hormone (TRH). TRH stimulates the anterior pituitary gland to release both TSH and prolactin. The resulting hyperprolactinemia causes bilateral galactorrhea and suppresses the hypothalamic-pituitary-ovarian axis, leading to oligomenorrhea. Treating the underlying hypothyroidism with levothyroxine will normalize TRH levels, which will subsequently normalize prolactin levels and resolve the patient's galactorrhea and menstrual irregularities without the need for further invasive testing or surgery.

Adım Adım Çözüm

1
Interpret the clinical presentation and physical exam.
The patient has bilateral milky nipple discharge (galactorrhea), oligomenorrhea, and classic symptoms of hypothyroidism (bradycardia, weight gain, fatigue, constipation).
Identifying the constellation of symptoms points toward a systemic endocrine issue rather than a localized structural breast pathology.
2
Analyze the laboratory data.
Prolactin is elevated. TSH is markedly elevated, and Free T4 is low.
This confirms the diagnosis of primary hypothyroidism causing secondary hyperprolactinemia.
3
Connect the pathophysiology of the abnormal labs.
Low Free T4 removes negative feedback on the hypothalamus, leading to increased thyrotropin-releasing hormone (TRH). TRH stimulates the anterior pituitary to secrete both TSH and prolactin.
Understanding this hormonal pathway explains why primary hypothyroidism directly causes galactorrhea.
4
Determine the most appropriate management.
Treating the root cause (hypothyroidism) with levothyroxine will restore negative feedback, lower TRH, and resolve both the elevated TSH and the hyperprolactinemia.
Targeted medical management of the primary endocrine deficiency prevents unnecessary imaging or invasive surgical interventions.

Anahtar Kavram

Bilateral galactorrhea can be caused by primary hypothyroidism due to TRH-mediated stimulation of lactotrophs; management requires thyroid hormone replacement.
Tahmini Süre:1m 0s
Sayfa 1 / 4Sonraki